Grown Rogue International Inc. Share Price
Stocks
GRIN
CA39986R3045
Pharmaceuticals
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.5600 CAD | +9.80% |
|
-3.45% | -20.00% |
| 05-12 | Grown Rogue International Inc., Q1 2026 Earnings Call, May 12, 2026 | |
| 05-12 | Grown Rogue International Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 | CI |
| Market Cap | 98.56M 86.54M 79.65M 74.22M 140M 9.37B 143M 958M 371M 4.6B 370M 362M 16.01B | P/E 2024 |
-12x | P/E 2025 | 71.9x |
|---|---|---|---|---|---|
| Enterprise Value | 114M 99.97M 92.02M 85.74M 162M 10.82B 165M 1.11B 429M 5.31B 428M 418M 18.49B | EV / Sales 2024 |
5.45x | EV / Sales 2025 | 4.4x |
| Free-Float |
61.83% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Grown Rogue International Inc.
| 1 day | +9.80% | ||
| 1 week | -3.45% | ||
| 1 month | -6.67% | ||
| 3 months | +40.00% | ||
| 6 months | -20.00% | ||
| Current year | -20.00% |
| 1 week | 0.51 |  | 0.6 |
| 1 month | 0.51 | | 0.68 |
| Current year | 0.38 | | 0.72 |
| 1 year | 0.38 | | 0.72 |
| 3 years | 0.21 | | 1.15 |
| 5 years | 0.06 | | 1.15 |
| 10 years | 0.06 | | 1.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Strickler
CEO | Chief Executive Officer | 45 | 14/11/2018 |
Sarah Strickler
PRN | Corporate Officer/Principal | - | 30/09/2016 |
| Director of Finance/CFO | 42 | 31/12/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Gledhill
BRD | Director/Board Member | 64 | 14/11/2018 |
J. Strickler
BRD | Director/Board Member | 45 | 14/11/2018 |
Ryan Kee
BRD | Director/Board Member | 42 | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-22 | Buy | Chief Financial Officer | 1,400 | 0.0006% | ||
| 01-19 | Mindset Capital LLC
| Buy | Company | 50,000 | 0.0200% | |
| 01-19 | Mindset Capital LLC
| Buy | Company | 50,000 | 0.0200% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +9.80% | -3.45% | +3.70% | +143.48% | 98.55M | |
| +1.27% | +0.71% | -13.99% | -8.59% | 12.6B | |
| +0.61% | +1.31% | -35.65% | -59.61% | 4.69B | |
| +1.50% | +3.86% | -10.98% | -13.86% | 4.35B | |
| +2.33% | -1.29% | +8.17% | -40.25% | 3.77B | |
| +2.98% | +1.05% | +13.17% | -14.61% | 3.77B | |
| +1.22% | -16.35% | -14.63% | -22.66% | 3.05B | |
| +2.80% | -1.52% | -13.38% | -6.27% | 2.99B | |
| +3.15% | -0.20% | -7.61% | -26.86% | 2.34B | |
| +3.04% | +0.91% | -11.05% | +24.35% | 1.66B | |
| Average | +2.87% | -0.23% | -8.22% | -2.49% | 3.93B | |
| Weighted average by Cap. | +1.80% | +0.96% | -10.96% | -19.11% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 27.02M 23.72M 21.83M 20.35M 38.37M 2.57B 39.15M 263M 102M 1.26B 101M 99.25M 4.39B | 32.43M 28.47M 26.21M 24.42M 46.06M 3.08B 46.99M 315M 122M 1.51B 122M 119M 5.27B |
| Net income | -11.3M -9.92M -9.14M -8.51M -16.05M -1.07B -16.38M -110M -42.57M -528M -42.44M -41.52M -1.84B | 1.73M 1.52M 1.4M 1.3M 2.46M 164M 2.51M 16.81M 6.51M 80.72M 6.49M 6.35M 281M |
| Net Debt | 3.7M 3.25M 2.99M 2.79M 5.26M 352M 5.37M 36.01M 13.95M 173M 13.91M 13.61M 602M | 15.3M 13.43M 12.36M 11.52M 21.73M 1.45B 22.17M 149M 57.62M 714M 57.44M 56.2M 2.48B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/06/26 | CA$0.5600 | +9.80% | 52,019 |
| 29/06/26 | CA$0.5100 | -10.53% | 23,347 |
| 26/06/26 | CA$0.5700 | -3.39% | 29,500 |
| 25/06/26 | CA$0.5900 | +1.72% | 4,000 |
| 24/06/26 | CA$0.5800 | -3.33% | 11,636 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- GRIN Stock
Select your edition
All financial news and data tailored to specific country editions
